Inhibrx Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD for Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Inhibrx Biosciences, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate for Q2 2024.
  • Inhibrx Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending May 30, 2024 was $1.8M.
Share-based Payment Arrangement, Expense, Quarterly (USD)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.